EX-FILING FEES 4 d657964dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Seres Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

      Security Type   Security
Class
Title
  Fee
Calculation
or Carry
Forward Rule
    Amount
Registered(3)
   Proposed
Maximum
Offering Price
Per Unit
   Maximum
Aggregate
Offering Price(3)
  Fee Rate    Amount of
Registration Fee

Fees to Be Paid

   Equity   Common Stock,
$0.001 par value per
share(1)
    -    -    -   -    -

Fees to Be Paid

   Equity   Preferred Stock,
$0.001 par value per
share(1)
    -    -    -   -    -

Fees to Be Paid

   Debt   Debt Securities     -    -    -   -    -

Fees to Be Paid

   Other   Warrants     -    -    -   -    -

Fees to Be Paid

   Other   Units     -    -    -   -    -

Fees to Be Paid

   Unallocated (Universal
Shelf)
  (2)     457(o)     $250,000,000    N/A    $250,000,000   0.0000927    $23,175

Fees Previously Paid

   Equity   Common Stock,
$0.001 par value per
share
    457(o)     $150,000,000    N/A    $150,000,000   0.0000927    $16,365(4)
   Total Offering Amounts       $250,000,000(4)      $23,175
             

 

   Total Fees Previously Paid            $16,365
             

 

   Total Fee Offsets           
             

 

   Net Fee Due            $6,810
             

 

 

  (1)

Includes rights to acquire Common Stock or Preferred Stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

  (2)

An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of additional shares of Common Stock is being registered as may be issued from time to time upon conversion of any Debt Securities that are convertible into Common Stock or pursuant to any anti-dilution adjustments with respect to any such convertible Debt Securities.

 

1


  (3)

Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of Common Stock that are issued upon conversion of Debt Securities or Preferred Stock or upon exercise of Common Stock Warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $250,000,000.

  (4)

The $250,000,000 of securities registered pursuant to this registration statement includes $150,000,000 of the registrant’s common stock that may be issued and sold under a certain sales agreement with Cowen and Company, LLC for which the registrant paid a registration fee of $16,365 at the time this registration statement was initially filed.

 

2